Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
1998
Molecular imaging in drug development
2008 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Cytogenetics in acute leukemia
2003
Acute Lymphoblastic Leukemia
1998
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy
1999
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
2010 Standout
LONG-TERM SURVIVORS OF CHILDHOOD CANCER
1997
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
1998 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study.
1993
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
1996 Standout
Knocking down barriers: advances in siRNA delivery
2009 Standout
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Childhood acute lymphoblastic leukemia
2002
From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1990
Preservation of Fertility in Patients with Cancer
2009 Standout
L‐asparaginase treatment in acute lymphoblastic leukemia
2010
Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response
1987
The impact of induction anthracycline on long‐term failure‐free survival in childhood acute lymphoblastic leukemia
1986
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
1985
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
1994
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
1990 StandoutNobel
Quantitative Analysis of Apoptotic Cell Death Using Proton Nuclear Magnetic Resonance Spectroscopy
1997
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
1994 Standout
The use and significance of biologic markers in the evaluation and staging of a child with cancer
1986
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia
1999 StandoutNobel
Flow cytometry in clinical cancer research.
1983
Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences
1985 StandoutNatureNobel
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia
1986
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion
1992
Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.
1985
Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
1982
Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations
1982 StandoutNobel
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
Monoclonal antibody-based therapies of leukemia and lymphoma
1992
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
1996
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas
1987
Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins
1995 StandoutNobel
Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
1982
Molecular Genetics of Acute Lymphoblastic Leukemia
2005
Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma
1983
The use of intermediate dose cytosine arabinoside (ID Ara‐C) in the treatment of acute non‐lymphocytic leukaemia in relapse
1984
Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia
2005
A clinical trial of anti-idiotype therapy for B cell malignancy
1985
Targeted drug delivery
1986
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
1982
Biological therapy of cancer
1986
Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
1984
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia
1984
In vivo detection and imaging of phosphatidylserine expression during programmed cell death
1998
Works of LA Clavell being referenced
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)
2000
Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
1987
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody
1981
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update)
1991
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody
1981
Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate
1983